Health Affairs January 7, 2025
Dylan Kacerek, T. Joseph Mattingly II

Prescription spending has increased substantially in recent years, growing to more than $630 billion in the US in 2022. Of that, approximately 51 percent of total pharmaceutical spending was on specialty drug products, increasing at a faster rate than non-specialty drug spending. In 2021, Delaware’s Department of Insurance found that 44 percent of total drug spending for fully insured commercial plans in Delaware came from 1 percent of the total pharmacy claims in their analysis.

The growing disproportionate amount of drug spending on such a small subset of pharmaceuticals has led many policy makers to focus on these specialty drug products. But this policy focus raises several fundamental questions such as: How is a specialty drug defined; who creates the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
The Future of Cancer Drug Development: Advancements, Challenges, and the Transformative Role of AI
J&J says its lung cancer drug combination keeps people alive longer
The Future Of Pharmacies In 3 Scenarios - 2
Will AI revolutionize drug development? Researchers explain why it depends on how it's used
CVS Health launches CostVantage model

Share This Article